Literature DB >> 29380805

Comment on: Femtosecond laser-assisted cataract surgery versus 2.2-mm clear corneal phacoemulsification.

Sagnik Sen1, Sudarshan Khokhar1, Neelima Aron1, Pragya Saini2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29380805      PMCID: PMC5819142          DOI: 10.4103/ijo.IJO_1143_17

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Sir, While congratulating the authors of “Femtosecond laser-assisted cataract surgery versus 2.2-mm clear corneal phacoemulsification” for elaborately comparing the outcomes of femtosecond laser-assisted cataract surgery (FLACS) with conventional method, we would like to bring to light certain points which we thought might be important in this context.[1] The authors found that 1-month postoperative endothelial cell loss (ECL) was higher with FLACS with no difference in postoperative central corneal thickness (CCT), without mentioning the intergroup P value. We applied parametric statistics to arrive at the intergroup P = 0.58 comparing the final CCT at 4 weeks. However, a percentage change of CCT in each group with comparative statistics should have been mentioned to arrive at the abovementioned conclusion. Although the authors have found a significantly higher ECL with FLACS, they have not mentioned the phacotorsional energy measured as cumulative dissipated energy which has significant effect on ECL apart from fluid usage or effective phaco time.[2] Phaco energy and time are the most important factors for endothelial damage, and FLACS may be beneficial by omitting need to sculpt and/or chop the nucleus, with similar results as studies comparing phaco chop with divide-conquer technique.[34] They have also not specified which mode of phacoemulsification was used; however, they did mention about the effective phaco time being lesser in FLACS (P < 0.001). The meta-analysis by Chen et al. did not find any reduction in ECL or CCT rise with FLACS as against one by Popovic et al. which found a significant reduction of ECL with no difference in surgical time.[5] In addition, an analysis by grade of cataract may be undertaken to further analyze the ECL in the harder grades over the lower ones to finally conclude, in which group of patients FLACS may be effectively a better option. We await a response eagerly.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Effects of phacoemulsification time on the corneal endothelium using phacofracture and phaco chop techniques.

Authors:  G Pirazzoli; D D'Eliseo; M Ziosi; R Acciarri
Journal:  J Cataract Refract Surg       Date:  1996-09       Impact factor: 3.351

2.  Effect of balanced phacoemulsification tip on the outcomes of torsional phacoemulsification using an active-fluidics system.

Authors:  Sudarshan Khokhar; Neelima Aron; Sagnik Sen; Ganesh Pillay; Esha Agarwal
Journal:  J Cataract Refract Surg       Date:  2017-01       Impact factor: 3.351

3.  Comparison of phaco-chop, divide-and-conquer, and stop-and-chop phaco techniques in microincision coaxial cataract surgery.

Authors:  Juwan Park; Hae Ri Yum; Man Soo Kim; Andrew R Harrison; Eun Chul Kim
Journal:  J Cataract Refract Surg       Date:  2013-07-31       Impact factor: 3.351

4.  Femtosecond laser-assisted cataract surgery versus 2.2 mm clear corneal phacoemulsification.

Authors:  H Ranjini; Praveen R Murthy; Gowri J Murthy; Vinay R Murthy
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

5.  Efficacy and safety of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification for cataract: a meta-analysis of randomized controlled trials.

Authors:  Xiaoyun Chen; Wei Xiao; Shaobi Ye; Weirong Chen; Yizhi Liu
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

  5 in total
  1 in total

1.  Reply to comment on: Femtosecond laser-assisted cataract surgery versus 2.2 mm clear corneal phacoemulsification.

Authors:  H Ranjini; Praveen R Murthy; Gowri J Murthy; Vinay R Murthy
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.